|
 |
nitrofurantoin monohydrate macrocrystalsThis page contains recent news articles, when available, and an overview of nitrofurantoin monohydrate macrocrystals but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.LAKE SUCCESS, NY -- Eon Labs, Inc. (Nasdaq: ELAB) announced that it received final approval today of Nitrofurantoin Monohydrate/Macrocrystals 100mg capsules ... $4.95 - Business Wire - ECNext Ranbaxy gets USFDA nod for capsules to treat urinary infection - Apr 2, 2005 RANBAXY Laboratories Ltd has received approval from the US Food and Drug Administration (USFDA) to manufacture and market Nitrofurantoin ... Hindu Business Line Press Release: Ranbaxy Receives FDA Approval to Market a Generic … - Apr 1, 2005 Ranbaxy Receives FDA Approval to Market a Generic Alternative to Macrobid(R). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Celebrating UC Success Announces Essay Contest Winners - May 12, 2008 NEW YORK, May 12 /PRNewswire/ -- The Crohn's & Colitis Foundation of America, in partnership with Procter & Gamble Pharmaceuticals (P&G), has selected seven ... RedOrbit Safety and Efficacy Results Presented From Largest Prospective … - May 20, 2008 SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- In a study presented today at the 39th Annual Digestive Disease Week (DDW) meeting in San Diego, California, ... RedOrbit Ranbaxy-NHS settlement at £4.5 million - Apr 2, 2005 New Delhi, April 1: Ranbaxy Laboratories and the UK Department of Health announced on Friday that the Indian major will pay the UK's National Health Service ... Financial Express Ranbaxy-NHS settlement at £4.5 million - Apr 7, 2005 Ranbaxy Laboratories and the UK Department of Health announced that the Indian major will pay the UK's National Health Service (NHS) £4.5 million (Rs 38.5 ... expresspharmapulse.com Manufacturers add to product portfolios.(approvals for drugs) - May 2, 2005 WASHINGTON -- Eon Labs Inc. has received final approval for nitrofurantoin monohydrate/macrocrystals capsules. The product, in a 100-mg dosage, ... Free with registration - Chain Drug Review - AccessMyLibrary.com New generics.(Rx) - Jun 20, 2005 Final approval for nitrofurantoin monohydrate/ macrocrystals 100-mg capsules has been granted to Eon Labs and to Ranbaxy Pharmaceuticals, Princeton, N.J., ... Free with registration - Drug Topics - AccessMyLibrary.com New generics.(drug approvals)(Brief Article) - May 2, 2005 Gabapentin capsules, in 100-, 300-, and 400-mg strengths, have been granted final FDA approval for two companies: Apotex Corp., Weston, Fla., (800) 706-557, ... Free with registration - Drug Topics - AccessMyLibrary.com Loislaw Federal District Court Opinions - MYLAN PHARMACEUTICALS, … - Sep 29, 2005 MYLAN PHARMACEUTICALS, INC. v. FOOD & DRUG ADMINISTRATION (NDWVa. 2005) MYLAN PHARMACEUTICALS, INC., Plaintiff, v. FOOD AND DRUG ADMINISTRATION, ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Eon Labs. - May 2, 2005 Eon Labs. Eon Labs received final FDA approval for nitrofurantoin monohydrate/macrocrystals 100 mg capsules, the generic equivalent to Procter & Gamble's ... $9.94 - Drug Store News - Alacra Store FDA Approves Ranbaxy's Generic Macrobid - Apr 6, 2005 The FDA has approved Ranbaxy Laboratories' abbreviated new drug application for nitrofurantoin monohydrate/macrocrystals capsules in a 100-mg dose. ... Pay-Per-View - FDAnews Drug Pipeline Alert - Factiva, from Dow Jones |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
